Abstract
The purpose of this placebo-controlled, randomized, double-blinded, parallel study was to determine the existence and magnitude of effect of various doses of fish oil supplements on International Normalized Ratio (INR) determinations in patients receiving chronic warfarin therapy. Patients from anticoagulation clinics from both the Brady Green Community Health Center and Audie L. Murphy Veterans Administration in San Antonio, Texas were enrolled in the study. The enrolled subjects included 5 males and 11 females, all of whom were receiving chronic warfarin therapy for indications requiring oral anticoagulation. All enrolled patients underwent a 4-week placebo monitoring period in which INRs were determined on a weekly basis. If the INRs were found to be stable, patients were randomized to receive a 4-week treatment period of either placebo capsules (n = 6), 3 grams of fish oil daily (n = 5), or 6 grams of fish oil daily (n = 5). Patients were followed on a twice-weekly basis for INR determinations and adverse reactions. Five patients were discontinued from the study due to noncompliance (2) and unstable INRs (3). There was no statistically significant difference in INRs between the placebo lead-in and treatment period within each group (P = 0.82). There was also no difference in INRs found between groups (P = 0.41). One bruising episode was reported, yet no major bleeding episodes were observed during the study. Fish oil supplementation in doses of 3–6 grams per day does not seem to create a statistically significant effect on the anticoagulation status of patients receiving chronic warfarin therapy.
Similar content being viewed by others
References
Haines AP, Sanders TA, Imeson JD, et al. Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics. Thromb Res 1986;43:643–655.
Atkinson PM, Wheeler MC, Mendelsohn D, et al. Effects of a 4-week freshwater fish (trout) diet on platelet aggregation, platelet fatty acids, serum lipids, and coagulation factors. Am J Hematol 1987;24:143–149.
Smith P, Arnesn H, Opstad T, et al. Influence of highly concentrated n-3 fatty acids on serum lipids and hemostatic variables in survivors of myocardial infarction receiving either oral anticoagulants or matching placebo. Thromb Res 1989;53:467–474.
Bussey HI, Force RW, Bianco TM, et al. Reliance on prothrombin time ratios cause significant errors in anticoagulation therapy. Arch Intern Med 1992;152:278–282.
Bussey HI, Chiquette E, Bianco TM, et al. Superiority of fingerstick to laboratory PT determinations. Arch Pathol Lab Med 1995;119:962–963.
Bang HO, Dyerberg J, Hjoorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976; 200:69–73.
Demke DM, Peters GR, Linet OI, et al. Effects of fish oil concentrate in patients with hypercholesterolemia. Atherosclerosis 1988;70:73–80.
Knapp HR, FitzGerald GA. The antihypertensive effects of fish oil: A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med 1989; 320:1037–1043.
Mehta JL, Lopez LM, Lawson D, et al. Dietary supplementation with omega-3 polyunsaturated fatty acids in patients with stable coronary heart disease: Effects on indices of platelet and neutrophil function and exercise performance. Am J Med 1988;84:45–52.
Bairati I, Roy L, Meyer F. Double blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 1992;85:950–956.
Dehmer GJ, Popma JJ, van den Berg EK, et al. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with omega-3 fatty acids. N Engl J Med 1988; 319:733–740.
Leaf A, Jorgensen MB, Jacobs AK, et al. Do fish oils prevent restenosis after coronary angioplasty? Circulation 1994;90: 2248–2257.
Cairns JA, Gill JB, Morton B, et al. Enoxaparine and Maxepa for the prevention of angioplasty restenosis (EMPAR). Circulation 1994;90(Suppl. 1):651.
Gapinski JP, VanRuiswyk JV, Heudebert GR, Schectman GS. Preventing restenosis with fish oils following coronary angioplasty. Arch Intern Med 1993;153:1595–1601.
Goodnight SH, Cairns JA, Fisher M, FitzGerald GA. Assessment of the therapeutic use of n-3 fatty acids in vascular disease and thrombosis. Chest 1992;102:374–384.
O'Connor GT, Malenka DJ, Olmstead EM, et al. A metaanalysis of randomized trials of fish oil in prevention of restenosis following angioplasty. Am J Prev Med 1992;8: 186–192.
Goodnight SH, Cairns JA. Therapeutic use of n-3 fatty acids for vascular disease and thrombosis. Chest 1995;108: 302S–304S.
Saynor R, Verel D, Gillot T. The long-term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets and angina. Atherosclerosis 1984; 50:3–10.
Knapp HR, Reilly IA, Alessandrini P, FitzGerald GA. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 1986;314:937–942.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bender, N.K., Kraynak, M.A., Chiquette, E. et al. Effects of Marine Fish Oils on the Anticoagulation Status of Patients Receiving Chronic Warfarin Therapy. J Thromb Thrombolysis 5, 257–261 (1998). https://doi.org/10.1023/A:1008852127668
Issue Date:
DOI: https://doi.org/10.1023/A:1008852127668